OPCM
LH icon

Osborne Partners Capital Management’s Labcorp LH Stock Holding History

Osborne Partners Capital Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Sell
753
-15
-2% -$3.94K 0.01% 197
2026
Q1 		$205K Buy
+768
New +$208K 0.01% 195
2025
Q4 		– Sell
-753
Closed -$216K – 208
2025
Q3 		$216K Buy
+753
New +$202K 0.01% 200

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Osborne Partners Capital Management's LH Position: Q2 2026 in Review

Osborne Partners Capital Management reduced its Labcorp (LH) stake by 2% in Q2 2026, selling an estimated $3.94K and leaving 753 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #197.

Osborne Partners Capital Management first reported a position in LH in Q3 2025 and has held it in 3 quarters since. The position peaked at $216K in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Osborne Partners Capital Management held 753 shares of Labcorp worth $211K as of Q2 2026.
  • Osborne Partners Capital Management sold 15 Labcorp shares in Q2 2026, an estimated $3.94K.
  • Labcorp made up 0.01% of Osborne Partners Capital Management's portfolio in Q2 2026, its #197 holding.
  • Osborne Partners Capital Management first reported a position in Labcorp in Q3 2025 and has held it in 3 quarters since.
  • Osborne Partners Capital Management's Labcorp position peaked at $216K in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Osborne Partners Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.